Methamphetamine is a key driver of the HIV epidemic in jurisdictions nationwide. HIV prevention and treatment, both key efforts in the EHE strategy are negatively affected by the meth crisis.
Presenters reviewed the epidemiology of the Methamphetamine epidemic as it relates to HIV, including biological changes that affect brain function, the psychodynamics of meth use and the implications for EHE efforts.
The webinar seeks to dispel the myth that very little can be done to engage and treat meth users to achieve positive outcomes. The presenters will share examples of evidence-based and evidence-informed interventions that can assist users to achieve better HIV and health outcomes, with a focus on contingency management (CM)
Purpose of the webinar, overview.
About Meth and the Brain (15:04)
An overview of impact of meth on brain and body, the connection between meth uses and HIV, and interventions available to treat people who have a stimulant use disorder.
Contingency Management in HIV Clinic to Address Meth Use (38:06)
An overview of how methamphetamine disrupts retention on medication-assisted treatment (MAT),MAT and contingency management, contingency management (CM) as an adjunct treatment, and more.
Hookup Apps for Sex and Meth (44:30)
An overview of studies on mobile apps and (un)happiness, hookup apps vs. recovery, and more.
The Regional TAP-in Structure (58:09)
TAP-in is available to help by addressing meth in your EHE strategies and more.
View TAP-in’s previous webinar, Addressing Substance Use Disorders as a Strategy to End the HIV Epidemic.